Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Breast and emerging indications for IORT

Dr David Martinez Perez - AUNA, Lima, Peru
Breast and emerging indications for IORT ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023

The advantages of IORT for early breast cancer treatment

Dr David Martinez Perez - AUNA, Lima, Peru
The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023

CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC

Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
26 Apr 2023

Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours

Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours ( Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA )
26 Apr 2023

Challenge mission to improve access to quality cancer care

Thet Ko Aung - City Cancer Challenge, Yangon, Myanmar
Challenge mission to improve access to quality cancer care ( Thet Ko Aung - City Cancer Challenge, Yangon, Myanmar )
25 Apr 2023

Choosing Wisely: An important step in the right direction

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Choosing Wisely: An important step in the right direction ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
25 Apr 2023

VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023

Cancer situation in Cambodia

Dr Kol Hero - Ministry of Health, Phnom Penh, Cambodia
Cancer situation in Cambodia ( Dr Kol Hero - Ministry of Health, Phnom Penh, Cambodia )
25 Apr 2023

Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023

Cancer Survivorship

Dr Lidia Schapira - Stanford Medicine, California, USA
Cancer Survivorship ( Dr Lidia Schapira - Stanford Medicine, California, USA )
20 Apr 2023

Cancer Care in Older Adults and Special Population

Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA
Cancer Care in Older Adults and Special Population ( Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA )
20 Apr 2023

Why tumour markers are not recommended as screening tests

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation